<DOC>
	<DOCNO>NCT02300792</DOCNO>
	<brief_summary>This study randomize , placebo control , double-blinded clinical trial , include 50 child hepatitis A . They sex age range 2 18 year . The patient randomly assign one two group ; consist 25 child . Each patient intervention group ( group 1 ) take oral honey dose 5 ml/kg/day ( maximum dose 150 ml/day ) four week , whereas patient placebo group ( group 2 ) take placebo form molasses . The main outcome measure recovery time define number day start intervention subsidence symptom sign hepatitis return liver transaminases normal level .</brief_summary>
	<brief_title>The Effects Honey , Dietary Supplement Children With Hepatitis A</brief_title>
	<detailed_description>This study randomize , placebo control double-blinded clinical trial , conduct Children 's Hospital Ain Shams university period November 2013 May 2014 . Eligible patient previously healthy child sex , age 2 18 year , develop manifestation acute hepatitis . Patients diabetes mellitus ( DM ) , chronic liver disease , autoimmune disorder , renal disorder , neurologic disease malignancy exclude study . Eighty nine eligible patient recruit outpatient Clinic Children 's Hospital Ain Shams university subject history taking , physical examination laboratory investigation form serum alanine aminotransferase ( ALT ) , serum aspartate aminotransferase ( AST ) , serum gamma gultamyltransferase ( GGT ) , serum bilirubin ( total direct ) assay Hepatitis A Virus IgM ( HAV IgM ) . Only patient positive HAV IgM candidate study . They seventy six patient randomly assign follow simple randomisation procedure ( computerized random number ) 1 2 group 1:1 allocation ratio . During study , total twenty six patient exclude ; nine patient stop trial refuse repeat blood sample investigation , six patient compliant honey intake ten patient lose follow . Fifty patient , thus complete study protocol include final analysis . Assuming mean duration acute illness 6 week mean ( ±SD ) duration acute illness intervention group 4 ( ±2 ) , total sample size 42 patient ( 21 per group ) require statistical power 90 % ( alpha=0 . 05 ) . Post- hoc test use power calculation . Each patient intervention group ( group 1 ) take oral honey dose 5 ml/kg/day ( maximum dose 150 ml/day ) four week . The dose honey empirical . Each patient placebo group ( group 2 ) take 5 ml molasses/kg/day ; maximum 150ml/day . Molasses honey-like substance make cane sugar process . It contain fat compose mainly sucrose , besides fructose glucose . The main outcome measure recovery time define number day start intervention subsidence symptom sign hepatitis return liver transaminases normal level . The main symptom sign hepatitis A fever , anorexia , nausea , vomit , abdominal pain , dark urine , clay-colored stool jaundice . Physical examination focus general condition , vital data , jaundice , hepatosplenomegaly ascites . The laboratory work consist measurement ALT , AST GGT kinetic method , measurement total direct bilirubin level colorimetric method , assay Anti-HAV IgM ELISA . Clinical laboratory evaluation patient do baseline ( 0 ) , 2nd week 4th week ( endpoint ) .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<criteria>Previously healthy child Hepatitis A.They sex age 2 18 year . Patients diabetes mellitus ( DM ) , chronic liver disease , autoimmune disorder , renal disorder , neurologic disease malignancy</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>honey , hepatitis A</keyword>
</DOC>